Overview

Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia

Status:
Completed
Trial end date:
2019-01-24
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate if a treatment the investigators call iCOMMIT is effective at helping smokers with schizophrenia stop smoking. iCOMMIT is a smoking cessation treatment that combines mobile technology with behavioral strategies, counseling, and medications.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Treatments:
Bupropion
Nicotine